Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - bimatoprost, quantity: 0.3 mg/ml - eye drops - excipient ingredients: sodium hydroxide; sodium chloride; hydrochloric acid; water for injections; benzalkonium chloride; citric acid monohydrate; dibasic sodium phosphate heptahydrate - for the reduction of elevated intraocular pressure, or open angle glaucoma, as first line therapy or monotherapy or as adjunctive therapy to topical beta- blockers.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - sodium nitroprusside, quantity: 50 mg - injection, solution - excipient ingredients: water for injections - dbl? sodium nitroprusside injection is indicated for:,1. immediate reduction of blood pressure in patients with hypertensive crises. concomitant oral antihypertensive medication should be started while the hypertensive emergency is being brought under control with sodium nitroprusside.,2. producing controlled hypotension during anaesthesia in order to reduce bleeding in surgical procedures where surgeon and anaesthetist deem it appropriate.,3. short term therapy of cardiac failure, to enhance cardiac output and lower myocardial oxygen requirements. patients should be commenced on oral therapy as soon as possible.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - sodium nitroprusside, quantity: 50 mg - injection, concentrated - excipient ingredients: water for injections - sodium nitroprusside baxter concentrated injection is indicated for:,1. immediate reduction of blood pressure in patients with hypertensive crises. concomitant oral antihypertensive medication should be started while the hypertensive emergency is being brought under control with sodium nitroprusside.,2. producing controlled hypotension during anaesthesia in order to reduce bleeding in surgical procedures where surgeon and anaesthetist deem it appropriate.,3. short term therapy of cardiac failure, to enhance cardiac output and lower myocardial oxygen requirements. patients should be commenced on oral therapy as soon as possible.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - bimatoprost, quantity: 300 microgram/ml - eye drops - excipient ingredients: sodium hydroxide; hydrochloric acid; dibasic sodium phosphate; benzalkonium chloride; citric acid monohydrate; water for injections; sodium chloride - bimtop is indicated for the reduction of elevated intraocular pressure, or open angle glaucoma, as first line therapy or monotherapy or as adjunctive therapy to topical beta- blockers.

Israel - English - Ministry of Health

rafa laboratories ltd - oxycodone hydrochloride - tablets controlled release - oxycodone hydrochloride 20 mg - oxycodone - oxycodone - for the relief of moderate severe chronic pain.

Israel - English - Ministry of Health

rafa laboratories ltd - oxycodone hydrochloride - tablets controlled release - oxycodone hydrochloride 10 mg - oxycodone - oxycodone - for the relief of moderate to severe chronic pain.

Israel - English - Ministry of Health

rafa laboratories ltd - oxycodone hydrochloride - tablets controlled release - oxycodone hydrochloride 80 mg - oxycodone - oxycodone - for the relief of moderate to severe chronic pain.

Israel - English - Ministry of Health

rafa laboratories ltd - oxycodone hydrochloride - tablets controlled release - oxycodone hydrochloride 40 mg - oxycodone - oxycodone - for the relief of moderate to severe chronic pain.

Israel - English - Ministry of Health

rafa laboratories ltd - oxycodone hydrochloride - tablets controlled release - oxycodone hydrochloride 5 mg - oxycodone - oxycodone - for the relief of moderate to severe chronic pain.

Israel - English - Ministry of Health

rafa laboratories ltd - oxycodone hydrochloride - tablets controlled release - oxycodone hydrochloride 5 mg - oxycodone - oxycodone - for the relief of moderate to severe chronic pain.